Περίληψη:
Convalescent plasma (CP) transfusion has been utilized as a salvage
therapy in immunocompromised patients with severe COVID-19 pneumonia. We
describe the case of a 45-year-old immunocompromised patient, who
received CP, in order to control multiple COVID-19 flares and prolonged
SARS-CoV-2 viraemia lasting for 2 months after the initial diagnosis.
Συγγραφείς:
Karaolidou, Frini
Loutsidi, Natasa-Eleni
Mellios, Zois and
Jahaj, Edison
Eleftheriou, Konstantinos
Pagoni, Maria and
Mpaltadakis, Ioannis
Dimopoulos, Athanasios-Meletios and
Kalomenidis, Ioannis
Pappas, Apostolos G.